• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 14 of 100
Woman stocks pill bottles on shelves
Health‘You’re the smoking cessation counselor, you’re the suicide prevention counselor’—waves of pharmacy closures nationwide take a toll
By The Associated Press, Tom Murphy and Kasturi PananjadyJune 3, 2024
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
NewslettersSanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
By Peter Vanham and Nicholas GordonMay 29, 2024
Plumes of smoke are seen after a fire broke out at an office building belonging to Danish pharmaceutical group Novo Nordisk in Bagsvaerd near Copenhagen, Denmark, on May 22, 2024.
RetailDanish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
By Sanne Wass, Naomi Kresge and BloombergMay 23, 2024
Dr. Razia Hashmi, vice president of clinical affairs, Blue Cross Blue Shield Association, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., on Tuesday, May 21, 2024.
HealthGLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
Emma Walmsley attends the 10th Annual Breakthrough Prize Awards and Ceremony at the Academy Museum of Motion Pictures in Los Angeles, California, United States
HealthHow GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
By Ashleigh Furlong, Sabah Meddings and BloombergMay 21, 2024
Photo of two boys riding in a cargo bike with their mother in downtown of Copenhagen
FinanceDenmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By Sanne Wass and BloombergMay 21, 2024
Pascal Soriot, chief executive officer of AstraZeneca Plc.
RetailAstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By Ashleigh Furlong and BloombergMay 21, 2024
woman shows off old oversized jeans
HealthHims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By Madison Muller, Jessica Nix and BloombergMay 20, 2024
woman measures her waist
HealthWeaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
TechGoogle DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By Jeremy KahnMay 8, 2024
Insulin injection pen
NewslettersHow the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
By Sheryl EstradaMay 3, 2024
Moderna CEO Stéphane Bancel at an event to encourage people to get updated COVID-19 booster shots on September 20, 2023 in Washington, DC.
HealthModerna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
By Sunny NagpaulMay 2, 2024
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
FinanceJohnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By Will DanielMay 1, 2024
AMR is on track to lower global life expectancy by an average 1.8 years by 2035, according to a new report from the Global Leaders Group on Antimicrobial Resistance.
HealthSuperbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
By Lindsey LeakeApril 25, 2024
A scientist in a lab coat peers into a microscope in a lab.
NewslettersAI for drug discovery draws a $1 billion launch—and a lot of hope
By Sage LazzaroApril 25, 2024
1...
  • 12
  • 13
  • 14
  • 15
  • 16
...100
Most Popular
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.